Wordt geladen...
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
INTRODUCTION. Immune checkpoint inhibitors (ICIs) have changed the oncologic landscape in the past few years. Alongside impressive antitumor responses, new novel immune‐related adverse events (irAEs) have emerged; pneumonitis is an irAE that can potentially be fatal and necessitates a proper managem...
Bewaard in:
| Gepubliceerd in: | Oncologist |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516115/ https://ncbi.nlm.nih.gov/pubmed/30777894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0352 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|